These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10802132)

  • 1. Four-year follow-up study of sertraline and fluvoxamine in long-term treatment of unipolar subjects with high recurrence rate.
    Franchini L; Gasperini M; Zanardi R; Smeraldi E
    J Affect Disord; 2000 Jun; 58(3):233-6. PubMed ID: 10802132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine and lithium in long-term treatment of unipolar subjects with high recurrence rate.
    Franchini L; Zanardi R; Gasperini M; Perez J; Smeraldi E
    J Affect Disord; 1996 Apr; 38(1):67-9. PubMed ID: 8735160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression.
    Franchini L; Gasperini M; Perez J; Smeraldi E; Zanardi R
    J Clin Psychiatry; 1997 Mar; 58(3):104-7. PubMed ID: 9108811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service.
    Weigmann H; Gerek S; Zeisig A; Müller M; Härtter S; Hiemke C
    Ther Drug Monit; 2001 Aug; 23(4):410-3. PubMed ID: 11477325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antidepressants.
    Kupecz D
    Nurse Pract; 1995 Sep; 20(9):64-7. PubMed ID: 7501318
    [No Abstract]   [Full Text] [Related]  

  • 6. Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.
    Inoue T; Honda M; Kawamura K; Tsuchiya K; Suzuki T; Ito K; Matsubara R; Shinohara K; Ishikane T; Sasaki K; Boku S; Fujisawa D; Ono Y; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):223-7. PubMed ID: 22504727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study.
    Terra JL; Montgomery SA
    Int Clin Psychopharmacol; 1998 Mar; 13(2):55-62. PubMed ID: 9669185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 24-month follow-up study of unipolar subjects: a comparison between lithium and fluvoxamine.
    Franchini L; Gasperini M; Smeraldi E
    J Affect Disord; 1994 Dec; 32(4):225-31. PubMed ID: 7897085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study.
    Zanardi R; Franchini L; Gasperini M; Smeraldi E; Perez J
    Int Clin Psychopharmacol; 1997 Jul; 12(4):195-7. PubMed ID: 9347379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
    Miljković BR; Pokrajac M; Timotijević I; Varagić V
    Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluvoxamine (fevarin) in the treatment of depression].
    Sheĭfer MS; Tsybina MI; Davydenko MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):64-7. PubMed ID: 11195542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of steroid-induced depression with low dosage of fluvoxamine.
    Yoshimura R; Ueda N; Nakamura J
    Aust N Z J Psychiatry; 2001 Dec; 35(6):855-6. PubMed ID: 11990900
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF; Lane RM; Zhu R; Ying Z
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of fluvoxamine for hemiballism in a patient with depressive disorder: a case report.
    Cayköylü A; Albayrak Y; Uğurlu GK; Ekinci O
    Acta Neurol Belg; 2011 Mar; 111(1):62-5. PubMed ID: 21510237
    [No Abstract]   [Full Text] [Related]  

  • 15. Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: the role of clinical, psychosocial and genetic variables.
    Dotoli D; Spagnolo C; Bongiorno F; Zanardi R; Serretti A; Smeraldi E; Franchini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):442-8. PubMed ID: 16431008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older community residents with depression: long-term treatment with sertraline. Randomised, double-blind, placebo-controlled study.
    Wilson KC; Mottram PG; Ashworth L; Abou-Saleh MT
    Br J Psychiatry; 2003 Jun; 182():492-7. PubMed ID: 12777339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
    Schaller JL; Behar D; Chamberlain T
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.
    Rufer M; Hand I; Alsleben H; Braatz A; Ortmann J; Katenkamp B; Fricke S; Peter H
    Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):121-8. PubMed ID: 15812606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvoxamine-methadone interaction.
    Alderman CP; Frith PA
    Aust N Z J Psychiatry; 1999 Feb; 33(1):99-101. PubMed ID: 10197892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant response and fluvoxamine plasma concentrations: a pilot study.
    Schwarzenbach F; Netillard C; Demoly P; Bisschop D; Limat S; Bouquet S; Vandel S; Bel AM; Woronoff-Lemsi MC
    Pharm World Sci; 2003 Feb; 25(1):27-9. PubMed ID: 12661474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.